David Shapiro, CMO and EVP - Development at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 2,234 shares at $112.18 ($251K) on 2017-05-01, disclosed to the SEC on 2017-05-03.
Seasonal sale ($251k) by CMO and EVP - Development — this insider has traded ICPT in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $112.18 | 1,117 | $125K | 50.0% |
| 2 | $112.18 | 1,117 | $125K | 50.0% |
| Total | $112.18 avg | 2,234 | $251K | 100% |
| Filing → |
| ICPT | SELL | 2019-04-03 | $129K | — | Filing → |
| ICPT | SELL | 2019-03-01 | $206K | — | Filing → |
| ICPT | SELL | 2019-02-20 | $223K | — | Filing → |